A Study of the Characteristics of Patients Diagnosed With Recurrent Symptomatic Genital Herpetic Disease
Sponsored by Rational Vaccines Inc
About this trial
Last updated 3 years ago
Study ID
RVx-001-PSS
Status
Completed
Type
Observational
Placebo
No
Accepting
18 to 64 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 3 years ago
What is this trial about?
Determine the baseline characteristics of patients who have recurrent symptomatic genital
herpetic disease Determine the acceptance to patients of clinical trial procedures Determine
interest in participation in genital herpes vaccine trials
What are the participation requirements?
Inclusion Criteria
- Able to understand and willing to sign the informed consent document.
- Patient confirmation of a diagnosis of HSV-2 infection at least 2 years prior to inclusion. Laboratory confirmation is not required.
- Symptomatic recurrent genital herpetic disease for >2 years supported by compatible clinical history
Exclusion Criteria
- Subjects who do not meet the inclusion criteria for the study
- Subjects who are unable to provide legally effective informed consent